- Joined
- May 16, 2007
- Messages
- 4,498
- Reaction score
- 1,687
Luvox for Covid-19. Published in Lancet Global Health. Link is in the article.
The previous study was very small. This is much larger.I remember seeing a segment on 60 minutes about fluvoxamine for COVID several months ago. I'm surprised that it hasn't been adopted as a common treatment today.
How many more large studies done my excellent researchers do you need? I'm not saying I would take it. It's not nothing. What's new is evidence, unlike just about everything else.Fluvoxamine was first discussed as an “alternative therapeutic” about 1 year ago. I remember this as a discussion in a meeting I attended last fall.
This is nothing new - and there is certainly not enough evidence YET to support or deny its role in the treatment of covid. More comprehensive studies are needed.
How many more large studies done my excellent researchers do you need? I'm not saying I would take it. It's not nothing. What's new is evidence, unlike just about everything else.
What are you talking about? Clearly the governments and politicians across the world have already saved mankind by contradicting themselves, policies, execution of said policies countless times repeatedly in an indecisive, grossly disorganized, and swift manner #sarcasmSure - I’m not diminishing the study. I’m just saying it’s quite premature. Who knows, maybe fluvoxamine will save the world.. But before I would say it’s going to save the world we should repeat the study, peer review it, and evolve the treatment.
The “repeat study, peer review, and evolve treatment” approach is becoming much less popular these days. However this is what we were taught in pharmacy school.
You do realize in a pandemic where millions of people have died, healthcare systems haven been overworked and economies damaged, no they are not going to wait 3 years?Sure - I’m not diminishing the study. I’m just saying it’s quite premature. Who knows, maybe fluvoxamine will save the world.. But before I would say it’s going to save the world we should repeat the study, peer review it, and evolve the treatment.
The “repeat study, peer review, and evolve treatment” approach is becoming much less popular these days. However this is what we were taught in pharmacy school.
You do realize in a pandemic where millions of people have died, healthcare systems haven been overworked and economies damaged, no they are not going to wait 3 years?
Yep look at the vaccine rollout.Sure - I’m not diminishing the study. I’m just saying it’s quite premature. Who knows, maybe fluvoxamine will save the world.. But before I would say it’s going to save the world we should repeat the study, peer review it, and evolve the treatment.
The “repeat study, peer review, and evolve treatment” approach is becoming much less popular these days. However this is what we were taught in pharmacy school.
I just don't like the hasty try anything nature of these potential treatments....risks vs. POTENTIAL? benefit is grossly ignored/an after thought. And these potential treatments vs. preventative measures like vaccination and continued social distancing practices & common sense in mitigating viral spread.Yes I do understand this. If you want to take ivermectin, hcq, fluvoxamine, ranitidine, zpac, and vitamin D to treat covid - I support your decision. 100%. As long as these drugs are not shortage for people who need them for common indications. I just don’t really care to get involved